Aadahl, M., Vardinghus-Nielsen, H., Bloch, P., Jørgensen, T. S., Pisinger, C., Tørslev, M. K., Klinker, C. D., Birch, S. D., Bøggild, H., & Toft, U. (2023). Our healthy community conceptual framework and intervention model for health promotion and disease prevention in municipalities.
International Journal of Environmental Research and Public Health, 20(5).
https://doi.org/10.3390/ijerph20053901Aravena, J. M., Chen, X., & Levy, B. R. (2024). Association between experiencing low healthcare quality and developing dementia.
Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18842Aslam, A. A., Baksh, R. A., Pape, S. E., Strydom, A., Gulliford, M. C., Chan, L. F., & Consortium, G.-D. (2022). Diabetes and obesity in Down syndrome across the lifespan: A retrospective cohort study using U.K. electronic health records.
Diabetes Care, 45(12), 2892–2899.
https://doi.org/10.2337/dc22-0482Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016). Dementia in Down’s syndrome.
The Lancet Neurology, 15(6), 622–636.
https://doi.org/10.1016/S1474-4422(16)00063-6Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021). Alzheimer’s disease associated with Down syndrome: A genetic form of dementia.
The Lancet Neurology, 20(11), 930–942.
https://doi.org/10.1016/S1474-4422(21)00245-3Gjora, L., Strand, B. H., Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., & Selbæk, G. (2021). Current and future prevalence estimates of mild cognitive impairment, dementia, and its subtypes in a population-based sample of people 70 years and older in Norway: The HUNT study.
Journal of Alzheimer’s Disease, 79(3), 1213–1226.
https://doi.org/10.3233/JAD-201275Hoffmann, K., Frederiksen, K. S., Sobol, N. A., Beyer, N., Vogel, A., Simonsen, A. H., Johannsen, P., Lolk, A., Terkelsen, O., Cotman, C. W., Hasselbalch, S. C., & Waldemar, G. (2013). Preserving cognition, quality of life, physical health and functional ability in Alzheimer’s disease: The effect of physical exercise (ADEX trial): Rationale and design.
Neuroepidemiology, 41(3–4), 198–207.
https://doi.org/10.1159/000354632Jónsdóttir, M. K., Pálsdóttir, E. B., Hannesdóttir, S. Ý., & Karlsson, T. (2022). Lay knowledge about dementia in Iceland: Symptoms and risk and protective factors.
Gerontology and Geriatric Medicine, 8, 23337214221142937.
https://doi.org/10.1177/23337214221142937Jorgensen, K., Nielsen, T. R., Nielsen, A., & Waldemar, G. (2023). Potential for prevention of dementia in Denmark.
Alzheimer’s & Dementia, 19(10), 4590–4598.
https://doi.org/10.1002/alz.13030Kinge, J. M., Klitkou, S. T., & Øien, H. (2023). Future disease-specific health spending and burden of disease in Norway, 2019 to 2040. Nordic Journal of Health Economics, 6(1), 104–115.
Kivipelto, M., & Hellénius, M-L. (2022). Brain health – At your fingertips. FINGERS Brain Health Institute.
Kjelvik, G., Rokstad, A. M. M., Stuebs, J., Thingstad, P., Deckers, K., Köhler, S., & Selbæk, G. (2022). Public knowledge about dementia risk reduction in Norway.
BMC Public Health, 22(1), 2046.
https://doi.org/10.1186/s12889-022-14433-wLarsen, F. K., Baksh, R. A., McGlinchey, E., Langballe, E. M., Benejam, B., Beresford-Webb, J., McCarron, M., Coppus, A., Falquero, S., Fortea, J., Levin, J., Loosli, S. V., Mark, R., Rebillat, A.-S., Zaman, S., & Strydom, A. (2024). Age of Alzheimer’s disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.
Alzheimer’s & Dementia, 20(5), 3270–3280.
https://doi.org/10.1002/alz.13779Last, J. M. (Ed). (2001). A dictionary of epidemiology, 4th ed. Oxford University Press.
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., . . . Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
The Lancet, 396(10248), 413–446.
https://doi.org/10.1016/s0140-6736(20)30367-6Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., Cooper, C., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Larson, E. B., Ritchie, K., Rockwood, K., Sampson, E. L., . . . Mukadam, N. (2017). Dementia prevention, intervention, and care.
The Lancet, 390(10113), 2673–2734.
https://doi.org/10.1016/s0140-6736(17)31363-6Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Nakasujja, N., Rockwood, K., Samus, Q., … Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.
The Lancet (London, England), 404(10452), 572–628.
https://doi.org/10.1016/S0140-6736(24)01296-0 McCarron, M., McCallion, P., Reilly, E., Dunne, P., Carroll, R., & Mulryan, N. (2017). A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.
Journal of Intellectual Disability Research, 61(9), 843–852.
https://doi.org/10.1111/jir.12390Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., Lindström, J., Mangialasche, F., Paajanen, T., Pajala, S., Peltonen, M., Rauramaa, R., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., . . . Kivipelto, M. (2015). A 2- year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial.
The Lancet, 385(9984), 2255–2263.
https://doi.org/10.1016/S0140-6736(15)60461-5Paauw, D., Heger, I., Bjerre, J. F., Ringgaard, M. F., Stensgård, V., Horstkötter, D., Köhler, S., & Deckers, K. (2024). Increasing awareness for dementia risk reduction through a public awareness campaign in Denmark: A pre-post study.
Preventive Medicine, 179, 107848.
https://doi.org/10.1016/j.ypmed.2024.107848Schramm, S., Bramming, M., Davidsen, M., Rosendahl Jensen, H. A., & Tolstrup, J. (2022).
Sygdomsbyrden i Danmark – risikofaktorer. Statens Institut for Folkesundhed, Syddansk Universitet. Sundhedsstyrelsen; Retrieved from
https://www.sst.dk/-/media/Udgivelser/2023/Sygdomsbyrden-2023/Risikofaktorer-Sygdomsbyrden-2023.ashxStrydom, A., Chan, T., King, M., Hassiotis, A., & Livingston, G. (2013). Incidence of dementia in older adults with intellectual disabilities.
Research in Developmental Disabilities, 34(6), 1881–1885.
https://doi.org/10.1016/j.ridd.2013.02.021Strydom, A., Coppus, A., Blesa, R., Danek, A., Fortea, J., Hardy, J., Levin, J., Nuebling, G., Rebillat, A-S., Ritchie, C., van Duijn, C., Zaman, S., & Zetterberg, H. (2018). Alzheimer’s disease in Down syndrome: An overlooked population for prevention trials.
Alzheimer’s & Dementia, 4(1), 703–713.
https://doi.org/10.1016/j.trci.2018.10.006Szklo, M., & Nieto, J. (2007). Epidemology: Beyond the basics. Jones and Bartlett Publishers
Valsdóttir, V., Magnúsdóttir, B. B., Gylfason, H. F., Chang, M., Aspelund, T., Gudnason, V., Launer, L. J., & Jónsdóttir, M. K. (2023). Exposure factors associated with dementia among older adults in Iceland: The AGES-Reykjavik study.
GeroScience, 45(3), 1953–1965.
https://doi.org/10.1007/s11357-023-00804-7Van Asbroeck, S., van Boxtel, M. P. J., Steyaert, J., Köhler, S., Heger, I., de Vugt, M., Ferhey, F., & Deckers, K. (2021). Increasing knowledge on dementia risk reduction in the general population: Results of a public awareness campaign.
Preventive Medicine, 147, 106522.
https://doi.org/10.1016/j.ypmed.2021.106522Wagner, C., Carmeli, C., Jackisch, J., Kivimaki, M., van der Linden, B. W. A., Cullati, S., & Chiolero, A. (2024). Life course epidemiology and public health.
Lancet Public Health, 9(4), e261–e269.
https://doi.org/10.1016/S2468-2667(24)00018-5Walsh, S., Govia, I., Peters, R., Richard, E., Stephan, B. C. M., Wilson, N-A., Wallace, L., Anstey, K. J. & Brayne, C. (2023). What would a population-level approach to dementia risk reduction look like, and how would it work?
Alzheimer’s & Dementia, 19(7), 3203–3209.
https://doi.org/10.1002/alz.12985Walsh S., Govia I., Wallace, L., Richard, R.,Peters, R., Anstey, K.J. et al. A whole-population approach is required for dementia risk reduction. Lancet Healthy Longev, 3 (1) (2022), pp. e6-e8.
WHO. (2019). Risk reduction of cognitive decline and dementia: WHO guidelines. World Health Organization.
Wolters, F. J., Chibnik, L. B., Waziry, R., Anderson, R., Berr, C., Beiser, A., Bis, J. C., Blacker, D., Bos, D., Brayne, C., Dartigues, J. F., Darweesh, S. K. L., Davis-Plourde, K. L., de Wolf, F., Debette, S., Dufouil, C., Fornage, M., Goudsmit, J., Grasset, L., . . . Hofman, A. (2020). Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium.
Neurology, 95(5), e519–e531.
https://doi.org/10.1212/WNL.0000000000010022